American Clinical Laboratory Association
- Company typePrivate
- Founded1971
- HeadquartersWashington, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
American Clinical Laboratory Association firmographics
Firmographics- Name
- American Clinical Laboratory Association
- Legal name
- American Clinical Laboratory Association
- Website
- https://acla.com
- Company type
- Private
- Founded year
- 1971
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Where American Clinical Laboratory Association is headquartered
LocationHeadquarters
- HQ city
- Washington
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
American Clinical Laboratory Association business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others, Technology or R&D
Revenue model
- Membership Dues: ACLA generates revenue through membership dues based on annual revenue. Membership eligibility requires clinical laboratory facilities certified by CLIA and accredited by the College of American Pathologists. Membership includes representation before legislative and regulatory bodies, participation in active committees, weekly conference calls, and meetings with key policymakers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Membership dues based on annual revenue |
Distribution channels1 record
Marketing channels6 records
American Clinical Laboratory Association product offering
Product offeringCore offering
American Clinical Laboratory Association (ACLA) is a national trade association that represents leading national, regional, and local clinical laboratories through policy advocacy before Congress, federal and state regulatory bodies, and other healthcare organizations. Its core deliverables include direct representation in PAMA/Medicare payment reform, regulatory advocacy (e.g., Laboratory Developed Tests), active member committees, weekly policy briefings, and engagement programs such as the Annual Membership Meeting.
Product overview
American Clinical Laboratory Association (ACLA) is a national trade association representing clinical laboratories, not a product company. It provides advocacy services, policy reform initiatives (including PAMA reform and the RESULTS Act), publishes resources and research on clinical laboratory value, and organizes events such as annual meetings for its member organizations. ACLA does not offer commercial products or services in the traditional sense.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Laboratory Membership Subscription membership for clinical laboratories providing representation before federal and state legislative and regulatory bodies, active committee participation (government reimbursement, state issues, CPT coding, legal, environmental/laboratory issues), weekly conference calls, and meetings with key policymakers. Available to CLIA-certified, CAP-accredited laboratories.
- Associate Membership Membership offering for manufacturers of diagnostic tests and technologies, pharmaceutical manufacturers, and professional service firms that support the laboratory industry, providing advocacy engagement and policy participation.
- ACLA Annual Membership Meeting Annual membership event delivering policy briefings, panel discussions with congressional staff, payers (BCBSA, AHIP), CMS, FDA, and AMA representatives, and networking across the clinical laboratory industry.
Quantifiable outcome
- Six in ten adults in the U.S. living with a chronic disease require routine monitoring supported by clinical laboratory tests
- +2 more outcomes
Companies that use American Clinical Laboratory Association
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
American Clinical Laboratory Association technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
American Clinical Laboratory Association partnerships and signals
Strategic signalPartnerships
14 partnerships are on record, tiered core and minor.
- Patient and Provider Organizationscore60+ patient and provider organizations have endorsed the RESULTS Act to protect patient access to clinical laboratory testing. These organizations represent millions of Americans and work with ACLA on legislative advocacy efforts.
- American Cancer Society Cancer Action NetworkcorePartnered on state-level biomarker legislation advocacy efforts that have led to the passage of groundbreaking biomarker laws in 20 states requiring Medicaid and private insurers to cover biomarker testing.
- The Cook Political Report with Amy WalterminorPolitical experts Amy Walter and David Wasserman provided perspectives on political trends, midterm election forecasts, and health care policy debates at the 2026 ACLA Annual Meeting.
- Blue Cross Blue Shield AssociationcoreBarb Liwosz, Director of Laboratory and Precision Medicine, discussed evolving payer strategies related to prior authorization, coverage policy, and laboratory reimbursement at the 2026 Annual Meeting.
- America's Health Insurance Plans (AHIP)coreKate Berry, Senior Vice President, outlined AHIP's work in advocacy, policy, and education including a collaborative initiative with Blue Cross Blue Shield and other insurers to streamline prior authorization.
- Myriad GeneticscorePaul Sheives, Vice President of Government Affairs at Myriad Genetics, co-presented on state-level advances in biomarker legislation with the American Cancer Society Cancer Action Network.
- Centers for Medicare & Medicaid Services (CMS)coreSarah Harding, Health Insurance Specialist at CMS, discussed Clinical Laboratory Fee Schedule payment policy and upcoming requirements for laboratories to report commercial market data.
- American Medical Association (AMA)coreZach Hochstetler, Vice President of CPT Coding and Payment at AMA, discussed processes that influence Clinical Laboratory Fee Schedule payment policy and coding decisions.
- U.S. Senate Finance Committee and House Energy and Commerce CommitteecoreSenior bipartisan health staff from key Senate and House committees discussed health policy priorities for the 119th Congress, including foundational PAMA reform at the 2026 ACLA Annual Meeting.
- Alston & Bird LLPcoreJane Lucas, former White House Counsel official and current Partner at Alston & Bird, discussed the federal health policy environment. Joyce Gresko, Partner and ACLA's General Counsel, moderated payer perspectives panel. Lori Denham and Mark Rayder provided legislative analysis.
- The Hargan GroupminorEric Hargan, former Deputy Secretary of HHS during the first Trump Administration and current CEO of The Hargan Group, discussed the Administration's approaches to health policy with Jane Lucas.
- Covington & Burling LLPcoreAmy Leiser, Special Counsel at Covington & Burling, discussed the future of regulation following the landmark ACLA v. FDA decision that vacated the FDA's LDT final rule.
- OPKO HealthcoreDr. Elias Zerhouni, former Director of the National Institutes of Health and current President of OPKO Health, discussed leadership, innovation, and the future of biomedical research at the 2026 Annual Meeting.
- Mayo Clinic LaboratoriescoreDr. William Morice, Board Chair of ACLA and President and CEO of Mayo Clinic Laboratories, led AI policy discussions and highlighted the ACLA Innovation Advisory Forum's work.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
American Clinical Laboratory Association competitors and assessment
Company assessmentBroad incumbents
- Biotechnology Innovation Organization (BIO): BIO represents the broader biotechnology industry and engages on regulatory, reimbursement, and innovation policy relevant to clinical laboratory diagnostics and precision medicine—competitively adjacent to ACLA's advocacy remit.
- American Medical Association (AMA): AMA represents physicians and operates the CPT coding process that underpins Clinical Laboratory Fee Schedule payment policy; ACLA and AMA overlap directly on coding and reimbursement advocacy through ACLA's CPT Committee.
- AdvaMed (Advanced Medical Technology Association): AdvaMed represents medical device and diagnostics manufacturers and overlaps with ACLA on diagnostic test regulation, LDT policy, and Medicare coverage—working both alongside and at times at arm's length from ACLA on shared issues.
- American Hospital Association (AHA): AHA is the national trade association for hospitals and health systems and engages on Medicare reimbursement, regulatory, and public health preparedness policies that parallel ACLA's federal advocacy interests.
- Pharmaceutical Research and Manufacturers of America (PhRMA): PhRMA represents biopharmaceutical manufacturers and works the same federal advocacy channels on Medicare, FDA regulation, and reimbursement frameworks that ACLA engages, with diagnostic-pharma convergence on personalized medicine.
Emerging players
- American Society for Microbiology (ASM): ASM represents microbiologists and infectious disease laboratory professionals, engaging on laboratory practice and public health preparedness themes that align with ACLA's clinical laboratory and pandemic-response advocacy.
Others
- College of American Pathologists (CAP): CAP is the accreditation body whose CAP accreditation status, alongside CLIA certification, governs ACLA member eligibility. It engages on laboratory standards, inspection, and pathology practice policy complementary to ACLA's advocacy.
Direct peers
- American Society for Clinical Pathology (ASCP): ASCP represents board-certified pathologists and laboratory professionals and engages on workforce, certification, and laboratory policy issues that directly intersect ACLA's advocacy mission for clinical laboratories.
- Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC): ADLM is a scientific and medical professional society for clinical laboratory medicine, with overlapping focus on laboratory practice standards, reimbursement, and regulatory advocacy for the clinical laboratory community served by ACLA.
- National Independent Laboratory Association (NILA): NILA represents independent and regional community clinical laboratories and pursues the same PAMA, CLFS, and LDT regulatory advocacy as ACLA, often with shared member companies and overlapping policy coalitions.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
American Clinical Laboratory Association social profiles
Digital presenceAmerican Clinical Laboratory Association financial estimates
Financial estimateRevenue estimate
Valuation estimate
American Clinical Laboratory Association leadership team
Management profileNumber of profiles
Profiles6 records
American Clinical Laboratory Association funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
American Clinical Laboratory Association M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about American Clinical Laboratory Association
What does American Clinical Laboratory Association do?
American Clinical Laboratory Association (ACLA) is a national trade association that represents leading national, regional, and local clinical laboratories through policy advocacy before Congress, federal and state regulatory bodies, and other healthcare organizations. Its core deliverables include direct representation in PAMA/Medicare payment reform, regulatory advocacy (e.g., Laboratory Developed Tests), active member committees, weekly policy briefings, and engagement programs such as the Annual Membership Meeting.
Is American Clinical Laboratory Association a public or private company?
American Clinical Laboratory Association is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was American Clinical Laboratory Association founded?
American Clinical Laboratory Association was founded in 1971. It employs 1 to 10 people.
Where is American Clinical Laboratory Association based?
American Clinical Laboratory Association is headquartered in Washington, United States, in the North America region.
How does American Clinical Laboratory Association make money?
One revenue line is on record: membership Dues.
Who are American Clinical Laboratory Association's main competitors?
Broad incumbents on record are Biotechnology Innovation Organization (BIO), American Medical Association (AMA), AdvaMed (Advanced Medical Technology Association), American Hospital Association (AHA) and Pharmaceutical Research and Manufacturers of America (PhRMA). American Society for Microbiology (ASM) is listed as an emerging player. College of American Pathologists (CAP) is listed as an others. Direct peers are American Society for Clinical Pathology (ASCP), Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) and National Independent Laboratory Association (NILA).
Does American Clinical Laboratory Association have an API?
No public API is recorded for American Clinical Laboratory Association.